These include ?-Discover/Lung DR, ?-Discover/ Mammo, ?-Discover/Stroke CT, and ?-Discover/Liver CT. In addition to launching four products at RSNA, the company will host two events during the exhibition, which takes place November 25 th -30 th. The first event, Machine Learning Theater Presentation, will be held on November 25 th.
NEW BRITAIN Hospital for Special Care recently announced that its Gawlicki Family Chronic Obstructive Pulmonary Disease Management program was recognized as the nation's first and only Patient Centered Specialty Practice. In 2017, the Gawlicki Family Foundation gave a $250,000 grant to Hospital for Special Care to support the hospital's efforts to.
The Advertising Self-Regulatory Council's National Advertising Division issued the following news release:. The National Advertising Division determined that Internet advertising claims made by Health Club Diet, LLC for its Androzene dietary supplement were unsupported and recommended that the advertiser's claims be discontinued.
Agency: " Centers for Medicare& Medicaid Services, HHS." SUMMARY: The Centers for Medicare& Medicaid Services is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of
Albany Medical Center issued the following news release:. The American College of Surgeons National Surgical Quality Improvement Program has recognized Albany Med as one of 83 ACS NSQIP participating hospitals that have achieved meritorious outcomes for surgical patient care in 2017. "Albany Med has an outstanding team of expert and dedicated surg
The American Medical Association issued the following news release:. The American Medical Association announced new policies on emerging health care issues that were adopted at the conclusion of the semi-annual meeting of the AMA House of Delegates. The AMA's House of Delegates is the policy-making body at the center of American medicine, bringing.
Apollo Hospitals Enterprise said Wednesday it is divesting its front-end pharmacy business to Apollo Pharmacy Ltd for a lump sum cash consideration of Rs 527.8 crore as part of a restructuring exercise. The board of directors of the company at its meeting held Wednesday decided "to segregate the front-end retail pharmacy business carried out in the
WESTMINSTER- ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended September 30, 2018 and provided a corporate update. Michael Bristow, ARCA's President and Chief Executive Officer.' FDA
Pharmaxis releases positive results of Phase 1 clinical trial for second LOXL2 inhibitor compound. LONDON, 15 November 2018: Arix Bioscience plc, a global healthcare and life science company supporting medical innovation, is pleased to note that Pharmaxis Ltd, an Australian pharmaceutical research company focused on inflammation and fibrosis, has..
Arix Bioscience plc, a global healthcare and life science company supporting medical innovation, is pleased to note that Pharmaxis Ltd, an Australian pharmaceutical research company focused on inflammation and fibrosis, has announced positive results from the Phase 1 clinical trial for the second of its Lysyl Oxidase Like 2 inhibitor compounds bein
-Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system disorders, today announced the completion of patient enrollment in the ASCEND study, a Phase 2 randomized, controlled trial of AXS-05 in major depressive disorder. ASCEND is evaluating the effect of AXS-05 a
Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases today reported enrolling its first patient in its Phase 3 preventive treatment of migraine trial with its lead oral calcitonin gene-related peptide receptor...
The report includes market shares of biosimilar market for global, Europe, North America, Asia Pacific and South America. Some of the major players operating in global biosimilar market are* 3 SBio Inc.* Allergan* Amgen Inc.* AstraZeneca* Baxter* Bharat Serums* Bio Sidus* Biogen* BioXpress TherapeuticsSA. Others: Emcure Pharmaceuticals Ltd., GeneSc
-BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, today announced positive results from a Phase 1 b study evaluating intravenously administered dexmedetomidine for acute treatment of agitation...
New York, NY 11/14/2018 A new market assessment report on Blood Pressure Monitoring Equipment market provides a comprehensive overview of Blood Pressure Monitoring Equipment industry for the forecast period 2018- 2025. The analytical study is proposed to provide immense clarity on the market size, share and growth rate across different region
In a petition filed with a Delaware bankruptcy court on Nov. 5, the company said it had debt exceeding $565 million, plus accrued and unpaid interest of $110 million, accrued expenses and accounts payable of about $94 million, and capitalized leases of about $13 million. According to the petition, the company has hired FTI Consulting Inc. to assist
-Bow River Capital 2017 Fund today announced that it has agreed to recapitalize Roseland Management, LLC, a physician practice management platform, in partnership with Precision Spine Care, PA, a leading physician group focused on the treatment of back and neck pain. In partnership with Bow River, Roseland Management will bring strategic, non-clini
-Acquired U.S. FDA- approved abbreviated new drug application from Laurus Labs Limited. ROCKVILLE, Md.- CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, today r
ROCKVILLE- CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, today reported financial results for the third quarter and nine months ended September 30, 2018 and.
The Center on Budget and Policy Priorities issued the following news release:. Arkansas became the first state to take Medicaid coverage away from people who don't meet a work requirement when it implemented its 1115 demonstration project in June. It's not surprising that a large share of Arkansas beneficiaries are losing coverage, because adding..
MISSISSAUGA- Concordia International Corp., an international specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines, today announced its financial and operational results for the three and nine months ended September 30, 2018. All financial references are in U.S. dollars unless otherwise noted.
SAN DIEGO- Cytori Therapeutics today announced Q3 2018 financial results and provided updates on corporate activities. Q3 2018 net loss was $2.3 million, or $0.27 per share. The Company recently received an orphan drug designation from the U.S. FDA for small cell lung cancer and intends to pursue FDA's 505 new drug application pathway in the U.S. w
Q3 2018 net loss was $2.3 million, or $0.27 per share. The Company recently received an orphan drug designation from the U.S. FDA for small cell lung cancer and intends to pursue FDAs 505 new drug application pathway in the U.S. which may offer accelerated and lower cost development. In the first half of 2019, Cytori expects a 1- year data readout
New York, NY 11/14/2018 A new market assessment report on Dental Surgical Instruments market provides a comprehensive overview of Dental Surgical Instruments industry for the forecast period 2018- 2025. The analytical study is proposed to provide immense clarity on the market size, share and growth rate across different regions. The profound
Biotest AG: Biotest AG acquires ninth plasma collection center in Germany ^ DGAP-News: Biotest AG/ Key word: Miscellaneous Biotest AG: Biotest AG acquires ninth plasma collection center in Germany 15.11. 2018/ 07:00 The issuer is solely responsible for the content of this announcement.